newsfilter
← Latest News
Business Wire·

Innate Pharma Reports First Half 2025 Business Update and Financial Results

IPH4502 Nectin-4 ADC Phase 1 enrollment progressing well: Preclinical update and Trial In Progress presented at AACR Annual Meeting 2025 and ASCO 2025 Annual Meeting. Lacutamab BTD and Phase 3 preparation: FDA